Autism Spectrum Disorder Symptoms Improve with Combination Therapy Directed at Improving Gut Microbiota and Reducing Inflammation
This blend pairs only BPC-157 and TB-500 at a 5+5 mg ratio in a 10 mg vial, focused on the angiogenic-plus-cytoskeletal pathway combination
Standard dosing has the strongest evidence for weight loss and metabolic improvement
Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6
This absorbs calcium and stimulates exocytosis of secretory granules, which in turn causes the release of insulin
PEMF (Pulse Electromagnetic Field Therapy): This therapy could complement the metabolic boost from Lipo-Mino-Mix-C by improving cellular function and overall bodily recovery, enhancing wellness and weight management efforts